These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 12065893)

  • 1. The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis.
    Reyes GR
    J Biomed Sci; 2002; 9(3):187-97. PubMed ID: 12065893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
    Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
    J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
    Gale M; Blakely CM; Kwieciszewski B; Tan SL; Dossett M; Tang NM; Korth MJ; Polyak SJ; Gretch DR; Katze MG
    Mol Cell Biol; 1998 Sep; 18(9):5208-18. PubMed ID: 9710605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
    Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
    J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.
    He Y; Nakao H; Tan SL; Polyak SJ; Neddermann P; Vijaysri S; Jacobs BL; Katze MG
    J Virol; 2002 Sep; 76(18):9207-17. PubMed ID: 12186904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
    Gale MJ; Korth MJ; Katze MG
    Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
    He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
    J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.
    Tan SL; Nakao H; He Y; Vijaysri S; Neddermann P; Jacobs BL; Mayer BJ; Katze MG
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5533-8. PubMed ID: 10318918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.
    Polyak SJ; Khabar KS; Paschal DM; Ezelle HJ; Duverlie G; Barber GN; Levy DE; Mukaida N; Gretch DR
    J Virol; 2001 Jul; 75(13):6095-106. PubMed ID: 11390611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity.
    Castelain S; Khorsi H; Roussel J; François C; Jaillon O; Capron D; Penin F; Wychowski C; Meurs E; Duverlie G;
    J Infect Dis; 2002 Mar; 185(5):573-83. PubMed ID: 11865413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase.
    Sarcar B; Ghosh AK; Steele R; Ray R; Ray RB
    Virology; 2004 Apr; 322(1):51-60. PubMed ID: 15063116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly.
    Nguyen LP; Tran SC; Suetsugu S; Lim YS; Hwang SB
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
    Noguchi T; Satoh S; Noshi T; Hatada E; Fukuda R; Kawai A; Ikeda S; Hijikata M; Shimotohno K
    Microbiol Immunol; 2001; 45(12):829-40. PubMed ID: 11838900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems.
    Khabar KS; Polyak SJ
    J Interferon Cytokine Res; 2002 Oct; 22(10):1005-12. PubMed ID: 12433279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The non-structural 5A protein of hepatitis C virus.
    Pawlotsky JM; Germanidis G
    J Viral Hepat; 1999 Sep; 6(5):343-56. PubMed ID: 10607250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
    François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
    J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A.
    Ezelle HJ; Balachandran S; Sicheri F; Polyak SJ; Barber GN
    Virology; 2001 Mar; 281(1):124-37. PubMed ID: 11222103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus NS5A: tales of a promiscuous protein.
    Macdonald A; Harris M
    J Gen Virol; 2004 Sep; 85(Pt 9):2485-2502. PubMed ID: 15302943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A.
    Hiet MS; Bauhofer O; Zayas M; Roth H; Tanaka Y; Schirmacher P; Willemsen J; Grünvogel O; Bender S; Binder M; Lohmann V; Lotteau V; Ruggieri A; Bartenschlager R
    J Hepatol; 2015 Oct; 63(4):829-37. PubMed ID: 25908268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment.
    Berg T; Mas Marques A; Höhne M; Wiedenmann B; Hopf U; Schreier E
    Hepatology; 2000 Dec; 32(6):1386-95. PubMed ID: 11093746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.